Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 8:28 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 121 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity, Abdominal Clear all

Conditions: Pre Diabetes, Polycystic Ovary Syndrome, Obesity Android
Interventions: Liraglutide Pen Injector [Saxenda], Placebo Liraglutide Pen Injector; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Cardiovascular Disease
Interventions: Almonds; Other
Lead sponsor: Penn State University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: HIV-Associated Lipodystrophy Syndrome, Insulin Resistance, HIV Infections, Metabolic Syndrome X, Body Weight Changes
Interventions: Rosiglitazone, Recombinant human growth hormone + rosiglitazone; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 4
States / cities: New York, New York

Conditions: Stress, Irritable Bowel Syndrome, Obesity, Abdominal Pain
Interventions: Standard of Care; Other
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 2 Years and older
Enrollment: 225 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pain, Postoperative, Postoperative Pain, Abdominal Pain, Obesity, Pneumoperitoneum
Interventions: Intraperitoneal Aerosolization System, IntraMyst; Device
Lead sponsor: Northgate Technologies; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 2
States / cities: Elk Grove Village, Illinois • Hoffman Estates, Illinois

Conditions: Obesity, Impaired Glucose Tolerance, Type 2 Diabetes Mellitus
Interventions: Rosiglitazone, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Subcutaneous Abdominal Adiposity
Interventions: LIPO-102, Placebo; Drug
Lead sponsor: Neothetics, Inc; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Anaheim, California • San Diego, California

Conditions: Diabetes Mellitus, Type 2, Insulin Resistance
Interventions: HydraSolve T2D™; Device
Lead sponsor: Medality Medical; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Wound Complications, Wound Infection, Wound Separation
Interventions: Prospective wound complication protocol; Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Dyslipidemias, Obesity
Interventions: Milk Polar Lipid-Rich Dairy Powder, Dairy Powder; Drug · Dietary Supplement
Lead sponsor: University of Connecticut; Other
Eligibility: 18 Years to 70 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Storrs, Connecticut

Conditions: Overweight and Obesity, Metabolic Syndrome
Interventions: Control, Overfeeding; Behavioral
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 42 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Visceral Obesity, Insulin Resistance
Interventions: Water-only fasting; Other
Lead sponsor: TrueNorth Health Foundation; Other
Eligibility: 40 Years to 70 Years
Enrollment: 48 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: Obesity, Intra-Abdominal Hypertension
Interventions: Respiratory mechanics assessment; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity, Acanthosis Nigricans, Central Obesity
Interventions: CHL program, Delayed Optimized CHL program; Other
Lead sponsor: University of Hawaii; Other
Eligibility: 2 Years to 8 Years
Enrollment: 9,840 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2020
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Overweight and Obesity, Overweight or Obesity, Obesity, Obesity, Morbid, Obesity, Abdominal, Obesity; Familial, Obesity; Endocrine, Obesity, Visceral, Obesity Hypoventilation Syndrome
Interventions: No intervention; Other
Lead sponsor: ProgenaBiome; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Ventura, California

Conditions: Obesity, Visceral, Cardiovascular Diseases, Fat Disorder
Interventions: Liraglutide, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 35 Years and older
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Central Abdominal Bulging
Interventions: LIPO-202, Placebo; Drug
Lead sponsor: Neothetics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 6
States / cities: Encinitas, California • Manhattan Beach, California • Aventura, Florida + 3 more

Conditions: Intra-Abdominal Hypertension, Inguinal Hernia
Interventions: Accuryn Monitoring System; Device
Lead sponsor: Antonios Likourezos; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Dyslipidemia, Obesity
Interventions: Freeze-dried strawberries, Dietary fiber; Dietary Supplement
Lead sponsor: Oklahoma State University; Other
Eligibility: 19 Years to 72 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Stillwater, Oklahoma

Conditions: Obesity, Abdominal, Insulin Sensitivity
Interventions: Workplace SSB sales ban, Brief Intervention; Other · Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 604 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Abdominal Obesity, Physical Activity
Interventions: Control, Resistance Exercise, Aerobic exercise; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metabolic Syndrome
Interventions: Not listed
Lead sponsor: University of Rochester; Other
Eligibility: 9 Years to 10 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Postmenopause
Interventions: conjugated estrogens, Raloxifene, exercise plus mild caloric restriction for weight loss; Drug · Behavioral
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 50 Years to 70 Years · Female only
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2006
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Obesity, Abdominal, Insulin Resistance, Insulin Sensitivity
Interventions: Avocado, Control; Other
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 25 Years to 45 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Urbana, Illinois

Search by objective public record fields.

Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS

Effects of Almonds on Cardiovascular Risk Factors

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Evaluating and Treating Potential Research Participants With Digestive Disorders

Intraperitoneal Aerosolized Delivery of a Local Anesthetic for Post Operative Pain Management. A Double Blind, Randomised Controlled Clinical Trial.

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity

Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes

A Study to Evaluate a Quality Improvement Intervention to Reduce Wound Separation Rates in Obese Gynecologic Oncology Service Patients Undergoing Abdominal Surgery

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Testing the Adipose Expandability Hypothesis In Vivo During Overfeeding

The Effects of Water-only Fasting and Refeeding on Body Composition

Chest Wall Influence on Respiratory System Mechanics in Morbidly Obese Patients

Children's Healthy Living Community Randomized Trial

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity

Impact of Liraglutide 3.0 on Body Fat Distribution

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

Measuring Intraabdominal Pressure, Lactic Acid, and Urine Output

Chronic Effects of Freeze-Dried Strawberry Beverage on Cardiovascular Risk Factors

Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational Counseling

Physical Activity in Overweight Girls: Implications for Reversing Risk Factors for Type 2 Diabetes

Examining the Relationship Between Tobacco Exposure, Abdominal Obesity, and Metabolic Syndrome in Adolescents (The STRONG Kids Study)

AFTER: Altering Fat Through Estrogen and Raloxifene

Persea Americana for Total Health (PATH ) Study